BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 18162152)

  • 1. [Incidence and pathological features of incidental prostate cancer and clinical significance thereof].
    Yang XY; Xia TL; He Q; Li W; Wang JH; Su JW; Li J; Na YQ
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(37):2632-4. PubMed ID: 18162152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of patients with stage T1b incidental prostate cancer.
    Argyropoulos A; Doumas K; Farmakis A; Aristas O; Kontogeorgos G; Lykourinas M
    Scand J Urol Nephrol; 2005; 39(4):289-93. PubMed ID: 16118104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does laser ablation prostatectomy lead to oncological compromise?
    Biers SM; Oliver HC; King AJ; Adamson AS
    BJU Int; 2009 Feb; 103(4):454-7. PubMed ID: 18782304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidental prostate cancer detected by cystoprostatectomy in Korean men.
    Joung JY; Yang SO; Seo HK; Kim TS; Han KS; Chung J; Park WS; Jeong IG; Lee KH
    Urology; 2009 Jan; 73(1):153-7. PubMed ID: 18407328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study of incidental carcinoma of the prostate. Part 1. Pathological analysis related to the clinical features].
    Fujita T; Kanimoto Y; Akino H; Okada K; Shiraishi T; Nakakuki K
    Hinyokika Kiyo; 1991 Jul; 37(7):695-703. PubMed ID: 1927769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidental prostate cancer in radical cystoprostatectomy specimens.
    Jin XD; Chen ZD; Wang B; Cai SL; Yao XL; Jin BY
    Asian J Androl; 2008 Sep; 10(5):809-14. PubMed ID: 18645685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective study of 101 cases with incidental prostate cancer stages T1a and T1b.
    Masue N; Deguchi T; Nakano M; Ehara H; Uno H; Takahashi Y
    Int J Urol; 2005 Dec; 12(12):1045-9. PubMed ID: 16409608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indications for preoperative prostate biopsy in patients undergoing radical cystoprostatectomy for bladder cancer.
    Thomas C; Wiesner C; Melchior S; Gillitzer R; Schmidt F; Thüroff JW
    J Urol; 2008 Nov; 180(5):1938-41; discussion 1941. PubMed ID: 18801501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinically significant prostate cancer found incidentally in radical cystoprostatectomy specimens.
    Abdelhady M; Abusamra A; Pautler SE; Chin JL; Izawa JI
    BJU Int; 2007 Feb; 99(2):326-9. PubMed ID: 17026595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radical prostatectomy for incidental (stage T1a-T1b) prostate cancer: analysis of predictors for residual disease and biochemical recurrence.
    Capitanio U; Scattoni V; Freschi M; Briganti A; Salonia A; Gallina A; Colombo R; Karakiewicz PI; Rigatti P; Montorsi F
    Eur Urol; 2008 Jul; 54(1):118-25. PubMed ID: 18314255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences between latent and clinical prostate carcinomas: lower cell proliferation activity in latent cases.
    Takahashi S; Suzuki S; Takahashi S; Inaguma S; Asamoto M; Shirai T
    Prostate; 2006 Feb; 66(2):211-7. PubMed ID: 16173032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probability of finding T1a and T1b (incidental) prostate cancer during TURP has decreased in the PSA era.
    Jones JS; Follis HW; Johnson JR
    Prostate Cancer Prostatic Dis; 2009; 12(1):57-60. PubMed ID: 18379587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. False positive labeling of prostate cancer with high molecular weight cytokeratin: p63 a more specific immunomarker for basal cells.
    Ali TZ; Epstein JI
    Am J Surg Pathol; 2008 Dec; 32(12):1890-5. PubMed ID: 18813120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate cancers diagnosed at repeat biopsy are smaller and less likely to be high grade.
    Tan N; Lane BR; Li J; Moussa AS; Soriano M; Jones JS
    J Urol; 2008 Oct; 180(4):1325-9; discussion 1329. PubMed ID: 18707706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia.
    Zhao Z; Liu J; Li S; Shen W
    Prostate; 2009 Sep; 69(12):1292-302. PubMed ID: 19462463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and factors predicting the detection of prostate cancer after transurethral resection of the prostate for clinically benign disease.
    Bright EA; Manuel C; Goddard JC; Khan MA
    Urol Int; 2009; 83(2):171-4. PubMed ID: 19752612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do clinically insignificant tumors of the prostate exist?
    Stamatiou K; Alevizos A; Mariolis A; Spiliopoulou C; Alevizou A; Bovis K; Sofras F
    Urol Int; 2008; 81(4):379-82. PubMed ID: 19077395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urothelial and incidental prostate carcinoma in prostates from cystoprostatectomies for bladder cancer: is there a relationship between urothelial and prostate cancer?
    Barbisan F; Mazzucchelli R; Scarpelli M; Lopez-Beltran A; Cheng L; Kirkali Z; Montironi R
    BJU Int; 2009 Apr; 103(8):1058-63. PubMed ID: 19076141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Derivatives of prostate-specific antigen as predictors of incidental prostate cancer.
    Froehner M; Buck LM; Koch R; Hakenberg OW; Wirth MP
    BJU Int; 2009 Jul; 104(1):25-8. PubMed ID: 19191782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency of impalpable prostate adenocarcinoma and precancerous conditions in Greek male population: an autopsy study.
    Stamatiou K; Alevizos A; Perimeni D; Sofras F; Agapitos E
    Prostate Cancer Prostatic Dis; 2006; 9(1):45-9. PubMed ID: 16314890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.